{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T00:01:42Z","timestamp":1788566502359,"version":"build-2803163510"},"reference-count":36,"publisher":"Georg Thieme Verlag KG","issue":"04","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Aktuelle Urol"],"published-print":{"date-parts":[[2024,8]]},"abstract":"<jats:title>Zusammenfassung<\/jats:title><jats:p>\n  Die \u00c4tiologie der neurogenen, nicht-obstruktiven Harnretention ist mannigfaltig. Neben zentralnerv\u00f6sen Erkrankungen kommen auch Erkrankungen des peripheren Nervensystems in Betracht. Die Restharnbildung kann zu erheblichen Problemen f\u00fchren, die die Patient*innen in ihrem t\u00e4glichen Leben enorm beeinflussen k\u00f6nnen. Nur eine differenzierte Diagnostik macht eine der Harnblasenfunktionsst\u00f6rung und auch der Lebenssituation der Patient*innen angepasste Therapie m\u00f6glich. Sowohl konservative als auch operative therapeutische Strategien stehen zur Verf\u00fcgung, medikament\u00f6se Therapieans\u00e4tze treten in den Hintergrund.\n    <\/jats:p><jats:p>\n    Als kausale Therapie der Funktionsst\u00f6rung sind insbesondere neuromodulative Verfahren geeignet. Wenn eine artifizielle Harnblasenentleerung notwendig wird, sollte der intermittierende Selbstkatheterismus wenn immer m\u00f6glich einem Dauerkatheter vorgezogen werden.\n    <\/jats:p>","DOI":"10.1055\/a-2266-4721","type":"journal-article","created":{"date-parts":[[2024,4,24]],"date-time":"2024-04-24T22:52:32Z","timestamp":1713999152000},"page":"337-343","source":"Crossref","is-referenced-by-count":1,"title":["Neurogene, nicht-obstruktive Harnretention: Diagnose und Therapie"],"prefix":"10.1055","volume":"55","author":[{"given":"Albert","family":"Kaufmann","sequence":"additional","affiliation":[{"name":"Neuro-Urologie, Schweizer Paraplegiker Zentrum, Nottwil, Schweiz"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorenz","family":"Leitner","sequence":"additional","affiliation":[{"name":"Neuro-Urologie, Universit\u00e4tsklinik Balgrist, Universit\u00e4t Z\u00fcrich, Z\u00fcrich, Schweiz"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"194","published-online":{"date-parts":[[2024,4,24]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1002\/nau.23897","article-title":"The International Continence Society (ICS) report on the terminology for adult male lower urinary tract and pelvic floor symptoms and dysfunction","volume":"38","author":"C D'Ancona","year":"2019","journal-title":"Neurourol Urodyn"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1016\/S1474-4422(15)00070-8","article-title":"Lower urinary tract dysfunction in the neurological patient: clinical assessment and management","volume":"14","author":"JN Panicker","year":"2015","journal-title":"Lancet Neurol"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1038\/nrurol.2014.286","article-title":"Contemporary concepts in the aetiopathogenesis of detrusor underactivity","volume":"11","author":"NI Osman","year":"2014","journal-title":"Nat Rev Urol"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1016\/j.eururo.2017.03.045","article-title":"Qualitative Exploration of the Patient Experience of Underactive Bladder","volume":"72","author":"AD Uren","year":"2017","journal-title":"Eur Urol"},{"key":"ref5","volume-title":"Non-neurogenic chronic urinary retention: consensus definition, management strategies, and future opportunities. AUA White Paper","author":"J Stoffel","year":"2016"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1055\/a-1352-9370","article-title":"Adverse drug reaction affecting the urinary tract \u2013 the Witten urinary tract adverse reaction score","volume":"52","author":"A Wiedemann","year":"2021","journal-title":"Aktuelle Urol"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1016\/j.eururo.2022.05.012","article-title":"European Association of Urology Guidelines on Male Urinary Incontinence","volume":"82","author":"M Gacci","year":"2022","journal-title":"Eur Urol"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.eururo.2022.01.045","article-title":"European Association of Urology Guidelines on the Diagnosis and Management of Female Non-neurogenic Lower Urinary Tract Symptoms. Part 1: Diagnostics, Overactive Bladder, Stress Urinary Incontinence, and Mixed Urinary Incontinence","volume":"82","author":"AK Nambiar","year":"2022","journal-title":"Eur Urol"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"2185","DOI":"10.1002\/nau.24113","article-title":"Are three-day voiding diaries feasible and reliable? Results from the Symptoms of Lower Urinary Tract Dysfunction Research Network (LURN) cohort","volume":"38","author":"AP Cameron","year":"2019","journal-title":"Neurourol Urodyn"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1097\/JU.0000000000003698","article-title":"Management of Lower Urinary Tract Symptoms Attributed to Benign Prostatic Hyperplasia (BPH): AUA Guideline Amendment 2023","volume":"211","author":"JS Sandhu","year":"2024","journal-title":"J Urol"},{"key":"ref13","volume-title":"Catheterisation Urethral Intermittent in adults","author":"S Vahr","year":"2017"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1111\/j.1464-410X.2006.06742.x","article-title":"Is the use of parasympathomimetics for treating an underactive urinary bladder evidence-based?","volume":"99","author":"MM Barendrecht","year":"2007","journal-title":"BJU Int"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1002\/nau.24039","article-title":"Alpha-blockers for treating neurogenic lower urinary tract dysfunction in patients with multiple sclerosis: A systematic review and meta-analysis. A report from the Neuro-Urology Promotion Committee of the International Continence Society (ICS)","volume":"38","author":"MP Schneider","year":"2019","journal-title":"Neurourol Urodyn"},{"key":"ref17","first-page":"P99","article-title":"Afferent nerve stimulation for pelvic floor dysfunction","volume":"10","author":"M Stoller","year":"1999","journal-title":"INTERNATIONAL UROGYNECOLOGY JOURNAL"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1186\/1471-2490-13-61","article-title":"Percutaneous Tibial Nerve Stimulation (PTNS) efficacy in the treatment of lower urinary tract dysfunctions: a systematic review","volume":"13","author":"G Gaziev","year":"2013","journal-title":"BMC Urol"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.1002\/nau.24694","article-title":"Efficacy of sacral neuromodulation and percutaneous tibial nerve stimulation in the treatment of chronic nonobstructive urinary retention: A systematic review","volume":"40","author":"FCS Ho","year":"2021","journal-title":"Neurourol Urodyn"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1016\/j.ucl.2010.06.007","article-title":"Neuromodulation and the neurogenic bladder","volume":"37","author":"FN Burks","year":"2010","journal-title":"Urol Clin North Am"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"1331","DOI":"10.1016\/s0022-5347(17)42038-6","article-title":"Electrical stimulation in the clinical management of the neurogenic bladder","volume":"140","author":"EA Tanagho","year":"1988","journal-title":"J Urol"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1186\/1471-2490-14-68","article-title":"Protocol for a prospective magnetic resonance imaging study on supraspinal lower urinary tract control in healthy subjects and spinal cord injury patients undergoing intradetrusor onabotulinumtoxinA injections for treating neurogenic detrusor overactivity","volume":"14","author":"L Leitner","year":"2014","journal-title":"BMC Urol"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.ucl.2004.09.004","article-title":"How sacral nerve stimulation neuromodulation works","volume":"32","author":"WW Leng","year":"2005","journal-title":"Urol Clin North Am"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1016\/j.euf.2019.11.018","article-title":"Sacral Neuromodulation: Mechanism of Action","volume":"6","author":"S De Wachter","year":"2020","journal-title":"Eur Urol Focus"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1038\/ncpuro1251","article-title":"Sacral neuromodulation for urinary retention","volume":"5","author":"TM Kessler","year":"2008","journal-title":"Nat Clin Pract Urol"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"2268","DOI":"10.1097\/01.ju.0000181806.59363.d1","article-title":"Changes in brain activity following sacral neuromodulation for urinary retention","volume":"174","author":"R Dasgupta","year":"2005","journal-title":"J Urol"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"1436","DOI":"10.1136\/bmj.297.6661.1436","article-title":"Abnormal electromyographic activity of the urethral sphincter, voiding dysfunction, and polycystic ovaries: a new syndrome?","volume":"297","author":"CJ Fowler","year":"1988","journal-title":"BMJ"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1016\/j.juro.2017.06.074","article-title":"Real-Time Changes in Brain Activity during Sacral Neuromodulation for Overactive Bladder","volume":"198","author":"BC Gill","year":"2017","journal-title":"J Urol"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1097\/00005392-200101000-00004","article-title":"Efficacy of sacral nerve stimulation for urinary retention: results 18 months after implantation","volume":"165","author":"U Jonas","year":"2001","journal-title":"J Urol"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1111\/j.1464-410X.2006.06521.x","article-title":"Different brain effects during chronic and acute sacral neuromodulation in urge incontinent patients with implanted neurostimulators","volume":"98","author":"BF Blok","year":"2006","journal-title":"BJU Int"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1016\/S0022-5347(05)00335-6","article-title":"Sacral neuromodulation in women with idiopathic detrusor overactivity incontinence: decreased overactivity but unchanged bladder contraction strength and urethral resistance during voiding","volume":"175","author":"J Groen","year":"2006","journal-title":"J Urol"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1002\/ana.21814","article-title":"Early sacral neuromodulation prevents urinary incontinence after complete spinal cord injury","volume":"67","author":"KD Sievert","year":"2010","journal-title":"Ann Neurol"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1100\/tsw.2011.13","article-title":"Sacral neuromodulation for refractory urge incontinence is less effective following spinal surgery","volume":"11","author":"AM Arlen","year":"2011","journal-title":"ScientificWorldJournal"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1002\/nau.21009","article-title":"Sacral neuromodulation for treating neurogenic bladder dysfunction: clinical and urodynamic study","volume":"30","author":"W Chaabane","year":"2011","journal-title":"Neurourol Urodyn"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"EVIDoa2200071","DOI":"10.1056\/EVIDoa2200071","article-title":"Sacral Neuromodulation for Neurogenic Lower Urinary Tract Dysfunction","volume":"1","author":"MD Liechti","year":"2022","journal-title":"NEJM Evid"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"319","DOI":"10.5213\/inj.2040364.182","article-title":"Long-term Outcomes of Sacral Nerve Stimulation in Pelvic Floor Dysfunctions","volume":"25","author":"D Hernandez-Hernandez","year":"2021","journal-title":"Int Neurourol J"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"1823","DOI":"10.1016\/j.neurom.2022.04.042","article-title":"Two-Staged Sacral Neuromodulation for the Treatment of Nonobstructive Urinary Retention: A Multicenter Study Assessing Predictors of Success","volume":"26","author":"RL Coolen","year":"2023","journal-title":"Neuromodulation"},{"key":"ref39","doi-asserted-by":"publisher","first-page":"528","DOI":"10.5999\/aps.2021.00402","article-title":"Latissimus dorsi detrusor myoplasty for bladder acontractility: a systematic review","volume":"48","author":"AJ Forte","year":"2021","journal-title":"Arch Plast Surg"},{"key":"ref40","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1007\/s11934-013-0349-2","article-title":"Latissimus dorsi detrusor myoplasty to restore voiding in patients with an acontractile bladder \u2013 fact or fiction?","volume":"14","author":"G van Koeveringe","year":"2013","journal-title":"Curr Urol Rep"}],"container-title":["Aktuelle Urologie"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/www.thieme-connect.de\/products\/ejournals\/pdf\/10.1055\/a-2266-4721.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,5]],"date-time":"2024-11-05T17:16:42Z","timestamp":1730827002000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.thieme-connect.de\/DOI\/DOI?10.1055\/a-2266-4721"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,24]]},"references-count":36,"journal-issue":{"issue":"04","published-online":{"date-parts":[[2024,7,24]]},"published-print":{"date-parts":[[2024,8]]}},"URL":"https:\/\/doi.org\/10.1055\/a-2266-4721","archive":["Portico","CLOCKSS"],"relation":{},"ISSN":["0001-7868","1438-8820"],"issn-type":[{"value":"0001-7868","type":"print"},{"value":"1438-8820","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,4,24]]}}}